Hypogonadism News

FDA Rejects Xyosted for Hypogonadism - MD Magazine



FDA Rejects Xyosted for Hypogonadism 
MD Magazine
Antares Pharma, QuickShot Testosterone, Hypogonadism, Xyosted The US Food and Drug Administration (FDA) has rejected the QuickShot Testosterone (XYOSTED) for the treatment of low testosterone levels associated with hypogonadism in adult males, ...

and more » 


Antares Pharma: A Company To Keep An Eye On - Seeking Alpha



Seeking Alpha
 
Antares Pharma: A Company To Keep An Eye On 
Seeking Alpha
Antares Pharma Inc.'s QuickShot Testosterone (XYOSTED) is awaiting Phase 3 approval by the FDA for treatment of low testosterone levels associated with hypogonadism. On the 12th of October, the company announced that it had received notice from the ...

 


DBVT Disappoints, GSK Gets Greenlight, AIMT Catches Eyes, FDA Snubs ATRS - Markets Insider



DBVT Disappoints, GSK Gets Greenlight, AIMT Catches Eyes, FDA Snubs ATRS 
Markets Insider
(RTTNews) - Today's Daily Dose brings you news about promising results from Albireo's phase II study of A4250 in children with cholestatic liver disease; Complete Response Letter for Antares' Xyosted, designed for treating hypogonadism in adult men; ...

and more » 


Male Health Drug Development ? Market Analysis Key Companies Mentioned Male Hypogonadism, Erectile ... - Medgadget (blog)



Male Health Drug Development ? Market Analysis Key Companies Mentioned Male Hypogonadism, Erectile ... 
Medgadget (blog)
The study covers geographic analysis and important players/vendors such as Male Hypogonadism, Erectile Dysfunction, Benign Prostatic Hyperplasia etc. The report will help user gain market insights, future trends and growth prospects for forecast.

and more » 


Is there such a thing as the male menopause? - Baxter Bulletin



Baxter Bulletin
 
Is there such a thing as the male menopause? 
Baxter Bulletin
While universal in women, loss of testosterone, leading to the male menopause, also known as ?late onset hypogonadism (decline in testicular function)", is much rarer. A recent study published in the New England Journal of Medicine conducted in healthy ...

 


Testosterone Patterns Predict Prostate Cancer Risk - Renal and Urology News



Renal and Urology News
 
Testosterone Patterns Predict Prostate Cancer Risk 
Renal and Urology News
In a study of 376 untreated hypogonadal men aged 45 to 74 years, PCa developed in 26 men during 2 to 11 years of follow-up, according to findings published in the Journal of Urology. The older a man was when his total testosterone fell to 12.1 nmol/L ...

 


Male Health Drug Development Pipeline Review, 2017 - PR Newswire (press release)



Male Health Drug Development Pipeline Review, 2017 
PR Newswire (press release)
Male hypogonadism is characterized by androgen deficiency and infertility. Hypogonadism can be caused by disorders at the hypothalamic or pituitary level (hypogonadotropic forms) or by testicular dysfunction (hypergonadotropic forms). There are a total ...

and more » 


CME: Can You Trust What You Read? - Medscape



CME: Can You Trust What You Read? 
Medscape
Healthcare professionals rely on certified continuing education programs to provide them with evidence-based, unbiased information. But is that always what they're getting? A recent study looked at programs on the topic of male hypogonadism and found ...

and more » 


Male Hypogonadism Market Research Report 2017 - E News Access (press release)



Male Hypogonadism Market Research Report 2017 
E News Access (press release)
Male Hypogonadism- Competitive Landscape, Pipeline and Market Analysis, 2017, report provides comprehensive insights about marketed and pipeline drugs across this Mechanism of action. Key objective of the report is to establish the understanding for ...

and more » 


Acerus Announces Licensing of NATESTO - Business Wire (press release)



Acerus Announces Licensing of NATESTO 
Business Wire (press release)
If approved, NATESTO® will be the first and only testosterone nasal gel for androgen replacement therapy in adult males for conditions associated with a deficiency or absence of endogenous testosterone (hypogonadism) in South East Asia.1.